The pan-PPAR agonist lanifibranor significantly improves cardiovascular risk biomarkers in patients with NASH

Francque, S; Cooreman, M; Baudin, M; Huot-Marchand, P; Dzen, L; Louis, JJ; Broqua, P; Abdelmalek, M

JOURNAL OF HEPATOLOGY, 2021; 75 (): S268

Abstract

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索